Albemarle Corporation
ALB
Classement en actions
#1867
Albemarle Corporation stands as a global innovator, producing and distributing... Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
Prix de l'action
$95.93
Capitalisation boursière
$11.32B
Changement (1 jour)
1.41%
Changement (1 an)
-0.22%
Pays
US
Échange Albemarle Corporation (ALB)
Catégorie
Basic Materials
Bénéfices pour Albemarle Corporation (ALB)
Bénéfices en Jun 2026 TTM : $272.91M
Selon les derniers rapports financiers de Albemarle Corporation, les bénéfices actuels de l'entreprise sont de $272.91M. En 2024, l'entreprise a réalisé un bénéfice de $-1.05B, une diminution par rapport à celui de 2023 qui était de $2.10B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Albemarle Corporation de 2000 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $272.91M | -140.29% |
| 2025 | $-677.38M | -35.39% |
| 2024 | $-1.05B | -149.90% |
| 2023 | $2.10B | -34.47% |
| 2022 | $3.21B | 1,297.51% |
| 2021 | $229.39M | -54.22% |
| 2020 | $501.04M | -11.00% |
| 2019 | $562.95M | -29.16% |
| 2018 | $794.70M | 77.87% |
| 2017 | $446.80M | -13.29% |
| 2016 | $515.26M | 43.85% |
| 2015 | $358.19M | 68.02% |
| 2014 | $213.18M | -60.84% |
| 2013 | $544.43M | 45.34% |
| 2012 | $374.59M | -31.97% |
| 2011 | $550.62M | 40.43% |
| 2010 | $392.10M | 144.65% |
| 2009 | $160.27M | -12.58% |
| 2008 | $183.34M | -34.01% |
| 2007 | $277.82M | 108.28% |
| 2006 | $133.39M | -11.03% |
| 2005 | $149.93M | 108.69% |
| 2004 | $71.84M | -18.41% |
| 2003 | $88.06M | -15.18% |
| 2002 | $103.81M | 6.81% |
| 2001 | $97.20M | -34.10% |
| 2000 | $147.50M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $9.50B | 3,382.13% |
GB
|
|
| - | - |
FR
|
|
| $3.49B | 1,179.48% |
US
|
|
| $2.63B | 863.58% |
US
|
|
| $-82.10M | -130.08% |
US
|
